Immunogenicity and Safety of Heterologous and Homologous Boosting With ChAdOx1-S and CoronaVac or a Formulation of SCB-2019 (COVID-19)

NCT05087368 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

520

Enrollment

OTHER

Sponsor class

Conditions

Covid19

Interventions

BIOLOGICAL: ChAdOx1-S COVID-19 Vaccine(Fiocruz/Oxford-AstraZeneca)
BIOLOGICAL: CoronaVac (Sinovac Biotech)
BIOLOGICAL: Adjuvanted Recombinant SARS-CoV-2 TrimericS-protein Subunit Vaccine (SCB-2019 - Clover)

Sponsor

D'Or Institute for Research and Education

Collaborators

[object Object]
[object Object]